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doi:10.1016/j.ejvs.2008.12.028Abstract Objectives: To evaluate whether contrast ultrasonography can be used to distin-
guish asymptomatic from symptomatic carotid plaques and provide insight into underlying
pathophysiological differences.
Design: Contrast Carotid ultrasound was performed in both symptomatic and asymptomatic
patients referred for carotid endarterectomy.
Materials and methods: Of 77 consecutive patients referred for carotid artery evaluation,
64 underwent carotid endarterectomy for asymptomatic cerebrovascular disease and 9 under-
went urgent surgery for acute neurological deficits with hemiparesis. The endarterectomy
specimens were assessed immunohistologically.
Results: In all 9 patients undergoing urgent surgery, contrast ultrasonography showed the
accumulation of diffuse microbubble contrast at the base of the carotid plaque. This pattern
was observed only in 1/64 of the patients undergoing surgery for asymptomatic carotid
disease. Immunohistologically staining of the endarterectomy specimens showed that the area
of microbubble contrast at the base of the symptomatic plaques was associated with an49970660; fax: þ39 6 49970572.
noni@uniroma1.it (M.F. Giannoni).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Angiogenesis in Symptomatic and Asymptomatic Plaques 723increased number of small diameter (20e30 mm) microvessels staining for vascular endothelial
growth factor (VEGF).
Conclusions: Contrast carotid ultrasonography may allow the identification of microvessels
with neoangiogenesis at the base of carotid plaques, and differentiate symptomatic from
asymptomatic plaques.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Ultrasonographic evaluation of carotid plaque morphology
represents, apart from the quantification of degree of
stenosis, is a fundamental tool to evaluate the risk of stroke
related to carotid disease.1 About 1/3 of cerebrovascular
accidents are indeed due to a hemodynamic or thrombo-
embolic event arising from a complicated carotid plaque.2
Many studies have indeed confirmed that the ‘‘unstable’’
plaque is heterogeneous, echolucent and with surface
ulcerations and that these features may be responsible for
both lesion progression and clinical symptoms.1,3e5 Never-
theless, the pathophysiological mechanisms underlying the
progression towards carotid plaque instability require
detailed elucidation.
Recent histological studies have demonstrated the
importance of inflammation and plaque angiogenesis in
the development and progression of the atheroma, and the
clinical association between inflammation, atherosclerosis
progression and cardio/cerebrovascular events has been
investigated.6e8 Neoangiogenesis occurs indeed regularly
within atherosclerotic plaques and symptomatic carotid
disease have been associated with an increased micro-
vessels’ density9,10 that, being immature and fragile, could
be more permeable to noxious inflammatory components
accumulating in the extracellular matrix of the media and
intimal layers, increasing the progression of vessel wall
disease, plaque functional activity and vulnerability.11
Carotid ultrasonography has been proven as a reliable
technique to image carotid atherosclerosis, providing
better definition of the arterial lumen, plaque morphology
and surface.12e14 More interestingly, contrast carotid
ultrasound may have the potential to visualize plaque
microvessels, thus allowing the study of pathophysiology of
the plaque ‘‘in vivo’’.15e19 The focus of this study was to
evaluate the characteristics of the carotid plaque with
contrast carotid ultrasonography and compare these find-
ings with post-operative plaque histology.Materials and Methods
Standard and contrast carotid ultrasound investigations
were performed in patients with documented severe
degree of internal carotid artery stenosis, referred to our
department for elective or emergency/urgent carotid
endarterectomy (CEA), in order to better define plaque
morphology and plaque neovascularization.
Patients
Of 77 consecutive patients referred for consideration of
carotid endarterectomy: (51 male and 26 female, mean age67 6), 64 underwent elective carotid endarterectomy for
asymptomatic cerebrovascular disease (no symptoms in
previous 6 months). Nine patients were symptomatic for
recent or acute neurological hemiparesis due to contralateral
internal carotid artery stenosis: these patients underwent
urgent surgerywithin 1week fromsymptomonset. Two further
patients with internal carotid artery occlusion were not
treated surgically and the remaining 2 patients were treated
endovascularly. The study was approved by the local ethical
committee and all patients gave written informed consent.
Ultrasound imaging protocol
Carotid duplex scanning was performed with an Acuson/
Siemens Sequoia 512, with the software ‘‘Cadence Contrast
Pulse Sequencing’’ (Cadence CPS). Linear phased array
probes (6, 8 and 15 Mhz) were used to assess carotid
plaques, with same presetting for all patients.
The best visualization of carotid plaques documented in B-
Mode, Color and Power modes on both longitudinal and
transversal scans were digitally stored. Angle corrected
blood flow velocities were obtainedwith pulsedwave Doppler
at the maximum site of stenosis. Plaque echographic
morphology has been described according to criteria already
well-established in literature20,21: plaqueswereconsidered as
hyperechoic with acoustic shadow, hyperechoic, isoechoic,
hypoechoic, and consequently as calcific, fibro-calcific
fibrous, fibro-fatty, haemorrhagic. Plaque surface was classi-
fied as regular, irregular and ulcerated, when a surface
irregularity of >2 mm was detected. Quantification of total
plaque echogenicity with computerized analysis of Gray Scale
Median (GSM) analysis was also performed.3,4 The degree of
stenosis was evaluated according to European Carotid Surgery
Trial (ECST) criteria,22 as percentage of the difference
between the original and the residual lumen at the maximum
site of stenosis and to the relative increase of blood flow
velocities.23
Contrast ultrasound investigation was performed as
already described elsewhere.15 A total amount of a full
dose of SonoVue (25 mg) contrast agent injection recon-
stituted with 5 ml of saline solution (Bracco Altana Pharma,
Konstanz, Germany) in an antecubital vein (20 gauge
Venflon) was performed in repeated bolus, the first, 1⁄2
dose (2.5 ml), followed by two other 1⁄4 doses (1.25 ml).
Each bolus was followed by a saline flush.
After identifying the plaque on longitudinal and trans-
verse scans, and after obtaining baseline B-mode, Color and
Power images of the plaque, the 15 Mhz linear array probe
with a mechanical index varying from 0.4 to 1.4 with
Cadence CPS continuous real-time recording software was
used to visualize plaque vascularization. This software is
based on the processing of nonlinear generated signals in the
fundamental frequency band that can improve sensitivity
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Agent only’’ software feature, in which the image is derived
only from the signals of the microbubbles, has been used.
The investigations were performed together by two different
experienced sonographers (EV, MFG), and digitally stored
onto an external hard-disk for off-line analysis. QONTRAST
Software by Bracco Imaging was also applied to color-code
contrast distribution within the plaque.
Histological sampling and immunohistochemical
studies
Carotid endarterectomy specimens, after fixation in 10%
buffered formalin and decalcification, if necessary, were
sliced transversely every 5 mm, embedded in paraffin and
stained with Movat’s pentachrome stains. For each plaque,
3e5 sections were examined according to the extension of
the plaque. Plaques were cut from the top edge to the
bottom on the longitudinal planes, to obtain a specimen that
was directly comparable with the bidimensional images
obtained at ultrasound. In the last 6 cases transversal planes
were obtained to evaluate the whole section of the plaque.
The sonographers (EV, MFG) instructed the pathologist,
blinded to clinical data, on how to perform the cut,
according to the regions of interested pre-identified at
ultrasound. Sections were probed with hematoxylineeosin
coloration, to have a general view of plaque cellularity, and
immunostained with antibodies for Vascular Endothelial
Growth Factor (VEGF) and Matrix MetalloProteinase 3 (MMP3)
(DAKO, Glostrup Denmark). The last 6 cases also were
stained for CD31 (1:100 dilution, purchased from Dako,
Glostrup, Denmark) and CD34 (1:4000 dilution, Dako) anti-
bodies markers for endothelial cells cocktail with an over-
night incubation at 4 C, with diaminobenzidine as the final
chromogen. To control for false positivity, immunostaining
was probed with the placenta and without the primary
antibody. Intraobserver agreement was 95%. The regions of
interest observed at ultrasound images were identified.
Results
Standard ultrasonography
All the 73 patients undergoing carotid endarterectomy pre-
sented with complicated plaques characterized by a hetero-
geneous echographic pattern, predominantly hypoechoic and
with irregular surface, determining severe internal carotid
stenosis.23 According to the criteria established3,4 for carotid
plaque GSM and cerebrovascular risk evaluation, themajority
(86.3%, 63 of 73)was classifiedasmajor risk plaques,withGSM
values <25. The remaining 10/73 (13.7%) had GSM values
higher than 25, due to the presence of small hyperechoic
calcified spots within the plaque. All 9 symptomatic patients
undergoing urgent surgery had very low GSM scores ranging
from 5 to 12. Asymptomatic patients had higher GSM values
than symptomatic ones (23.4 8 versus 9.1 3; Manne
Whitney p< 0.0001).
Contrast ultrasound imaging
In all 64 asymptomatic patients weak, discrete contrast-
enhancement was detected mainly in the hypo-isoechoicareas, corresponding to fibrous and fibro-fatty tissue (Fig. 1).
Isolated microvessels, readily identifiable by high intensity
spots of microbubbles running from the adventitial layers
towards the vessel lumen, were the main vascularization
pattern (type I, Table 1). Vascularization was not detected
either in the hyperechoic with acoustic shadow calcified
tissue,or in thehypoechoicnecrotic andhaemorrhagicareas.
In the 9 acute symptomatic patients a completely
different pattern of contrast enhancement was detected
(Fig. 2). In the first seconds after contrast agent adminis-
tration, little contrast was identified in the hypoechoic
areas (type I pattern observed in 5/9 patients). A few
seconds later, a major diffuse area of contrast enhance-
ment appeared at the base of the plaques, due to an
agglomerate of many very small microvessels, difficult to
differentiate from each other (type II, Table 1). The
residual hypoechoic part of the plaque, corresponding to
the necrotic or haemorrhagic contents, remained without
contrast. A similar pattern of contrast was observed in only
1/64 asymptomatic plaques, in a patient who had pre-
sented with a stroke 2 years earlier. Therefore the presence
of microbubble contrast at the base of the plaque was
associated strongly with the presence of symptomatic pla-
que (1/64 versus 9/9, Fisher exact test p< .0001).
Histology and microvessel diameter
Histological examination confirmed the presence of vascu-
larization at the base of all 9 symptomatic plaques,
consistent with the presence of ultrasound contrast-
enhanced areas. All symptomatic carotid plaques contained
an increased number of small (diameter 20e30 mm),
immature microvessels at their base consistent in with
strong neoangiogenetic activity (black arrows in Fig. 2 E).
Microvessels and angiogenesis were less evident in asymp-
tomatic plaques, with microvessel diameter being of larger
diameter (>50 mm) (Black arrows in Fig. 1E).
Immunohistochemical staining
Immunostaining for VEGF and MMP3 revealed different
patterns for asymptomatic and symptomatic plaques. In
asymptomatic plaques immunostaining was slight and
localized mainly along the course of the scant microvessels.
In symptomatic plaques high intensity immunostaining was
observed in the adventitial aspect of the plaque, associated
with the presence of small diameter microvessels. In the
single asymptomatic patient with type II contrast
enhancement in the plaque, numerous microvessels were
detected under the fibrous cap in the shoulder of the
atheroma, clearly identified after CD31 and CD34
immunostaining.
Discussion
The NASCET24 and the ECST22 trials clearly demonstrated
that carotid endarterectomy significantly reduces the risk
of neurological events in patients with severe internal
carotid stenosis. Nevertheless, the risk of thromboembolic
events is related more to the instability of the atheroma
than to the extent of disease.6,7 Further, the identification
Figure 1 Asymptomatic patient: Duplex scan (A) of a heterogeneous, mainly hypoechoic with few hyperechoic with acoustic
shadow spots, smooth surface plaque, determining severe carotid stenosis. Macroscopic findings (B) show the presence of
a complicated, haemorrhagic plaque. Immunohistological staining for VEGF (C, 20) shows minimal angiogenesis, with a single
small microvessel (50e60 mm diameter, black arrow in C). Contrast Cadence CPS (D) shows minimal contrast enhancement of the
lesion, corresponding to a minimal vascularization in the corresponding histological sampled area (dot red box). Qontrast software
imaging analysis of the distribution of plaque vascularization (E).
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computerized assessment, has been identified as an accu-
rate objective tool for the evaluation of unstable pla-
ques.3,4 Data collected from literature have indeed
demonstrated that low GSM plaques, composed of hae-
morrhage and lipidic necrotic core, are associated with an
increased risk of embolic events.5,20,21 However, the
pathophysiological mechanisms responsible of the
progression towards carotid plaque instability still remain
to be better elucidated.Table 1 Assessment of plaques by echogenicity by Gray Scale M
distribution.
Asymptomatic
GSM 23.4 8
Type I
(rare, discrete contrast
enhancement with microvessels of
large diameter 50e60 mm)
64/64
Type II
(diffuse contrast enhancement,
with microvessels of small
diameter, 20e30 mm, with VEGF
staining, at the base of the plaque)
1/64Recent studies have observed that plaque instability is
a dynamic process in which inflammation and neoangio-
genesis are linked to atherosclerotic progression and
development of neurological events.25,26 Moreover, recent
histological studies have observed that stable plaques are
characterized by a low grade chronic inflammatory infil-
trate, whereas unstable and symptomatic plaques are
characterized by an active inflammation and ‘‘plaque
activity’’ processes, involved in the thinning of the fibrous
cap and thus predisposing to the plaque rupture.6e8 A highedian (GSM), contrast enhancement and microvessel size and
plaques (nZ 64) Symptomatic plaques (nZ 9)
9.1 3
5/9
9/9
Figure 2 Acute symptomatic patient: Duplex scan (A) of a heterogeneous, mainly hypoechoic with a proximal posterior
hyperechoic calcified area, irregular surface plaque and severe carotid stenosis. Macroscopic findings (B) show a complicated
plaque, with haemorrhage in the proximal anterior section that was opened during the endarterectomy (black arrow). Immuno-
histological staining for VEGF (C, 20) shows diffuse staining, with multiple small microvessels (20e30 mm diameter, black arrows in
C) with strong staining towards the base of the plaque (dot red box in E). Contrast Cadence CPS mode (D early phase, E late phase)
shows high diffuse contrast enhancement consistent with vascularization at the base of the lesion, which is more evident in the late
phase. Qontrast software imaging analysis of the distribution of plaque vascularization (F).
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number of infiltrating mononuclear cells, suggesting that
neovessels are an important route for the entry for leuko-
cytes and inflammatory cells into advanced lesions, to
correlate with development of clinical symptoms.8 These
processes have not been subject to ‘‘in vivo’’ imaging
techniques, which are considered as the ‘‘gold standard’’
for the demonstration of the direct temporal correlation
between inflammation, angiogenesis and developing of
clinical symptoms in carotid atherosclerosis.
Our pilot study indicates that contrast ultrasonography has
considerable potential as an ‘‘in vivo’’ imaging technique of
plaque vascularization and neovascularization. Patients with
acute symptomatic disease showed predominantly a specific
pattern of diffuse contrast enhancement at the base of the
plaques, close to the adventitial layer, corresponding toa high
density of small diameter microvessels. The histological
specimensof thesepre-selectedareas showedthepresenceof
small microvessels with high density, to confirm the presence
ofplaqueneoangiogenesis in the acute symptomatic patients.
On the other hand, the vascularization pattern was very
different in patients with asymptomatic disease, with more
mature larger diameter microvessels, diffusely distributed.
Further prospective data is necessary to confirm and extend
our findings and to assess the role of the detection of plaque
vascularization in the work-up of patients presenting with
cerebrovascular disease.Study limitations
The major limitation of this approach is the subjective char-
acterisation of the patterns of contrast enhancement. An
objective quantitative method of assessing contrast
enhancement remains to be developed. Additional immuno-
histology, including CD31 staining with image analysis, to
quantify microvessels also is required.
Conclusion
Contrast carotid ultrasound investigation is a reliable non-
invasive technique, with the potential for investigating the
severity and pathophysiology of carotid artery plaques ‘‘in
vivo’’ and in ‘‘real time’’.
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